The University of Birmingham is a public research university located in Edgbaston, Birmingham, United Kingdom. It received its royal charter in 1900 as a successor to Queen's College, Birmingham, and Mason Science College, making it the first English civic or 'red brick' university to receive its own royal charter.

During the past decade, University of Birmingham conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 5 clinical trials were completed, i.e. on average, 27.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Birmingham" #1 sponsor was "University of Birmingham" with 18 trials, followed by "Medical Research Council" with 6 trials sponsored, "Gynecologic Oncology Group" with 3 trials sponsored, "Mirum Pharmaceuticals, Inc." with 3 trials sponsored and "University Hospital Birmingham" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Birmingham" #1 collaborator was "British Heart Foundation" with 4 trials as a collaborator, "University of Birmingham" with 4 trials as a collaborator, "GlaxoSmithKline" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator and "University of Oxford" with 3 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "University of Birmingham" are "Bladder Cancer" (3 trials), "Breast Cancer" (3 trials), "Lymphoma" (3 trials), "Ovarian Cancer" (3 trials) and "Primary Biliary Cirrhosis" (3 trials). Many other conditions were trialed in "University of Birmingham" in a lesser frequency.

Most popular intervention types in "University of Birmingham" are "Drug" (29 trials), "Other" (14 trials), "Procedure" (7 trials), "Behavioral" (6 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "LUM001" (3 trials), "laboratory biomarker analysis" (3 trials), "radiation therapy" (3 trials) and "Exercise" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Birmingham" are 44 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "University of Birmingham". 1 are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 34 completed trials in University of Birmingham, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Birmingham, 5 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 14 trials that are defined as “Not Applicable".

University of Birmingham has several departments that took part in Clinical trials: "University of Birmingham, School of Sport, Exercise and Rehabilitation Sciences" - 11 trials, "Cancer Research UK Clinical Trials Unit - Birmingham" - 7 trials, "The School of Dentistry, University of Birmingham" - 5 trials, "University of Birmingham School of Psychology" - 2 trials, "College of Medical and Dental Sciences" - 2 trials, "City Hospital Birmingham Cancer Trials Team" - 2 trials